This meta-analysis combined published data from studies on MALAT-1 expression and NSCLC prognosis, to determine if MALAT-1 expression has prognostic and clinicopathological significance in patients with NSCLC. The gene discussed is MALAT1; the disease is non-small cell lung carcinoma.